Real Time Touch

new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)

Real Time Touch

Ligand Pharmaceuticals Incorporated patents (2015 archive)

Recent patent applications related to Ligand Pharmaceuticals Incorporated. Ligand Pharmaceuticals Incorporated is listed as an Agent/Assignee. Note: Ligand Pharmaceuticals Incorporated may have other listings under different names/spellings. We're not affiliated with Ligand Pharmaceuticals Incorporated, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "L" | Ligand Pharmaceuticals Incorporated-related inventors

09/10/15 / #20150252043

Hematopoietic growth factor mimetic small molecule compounds and their uses

The present embodiments relate to compounds with physiological effects, such as the activation of hematopoietic growth factor receptors. The present embodiments also relate to use of the compounds to treat a variety of conditions, diseases and ailments such as hematopoietic conditions and disorders.. ... Ligand Pharmaceuticals Incorporated

09/03/15 / #20150246068

Novel nucleotide prodrug compounds and use

Embodiments of the present invention include nucleoside 5′-monophosphate derivative compounds, their preparation and their uses. In some embodiments, nucleoside 5′-monophosphate derivative compounds are useful to treat viral infections.. ... Ligand Pharmaceuticals Incorporated

06/18/15 / #20150164865

Oral formulations of diphenylsulfonamide endothelin and angiotensin ii receptor agonists to treat elevated blood pressure and diabetic nephropathy

Methods of administering and pharmaceutical compositions of a biphenyl sulfonamide compound which is a dual angiotensin and endothelin receptor antagonist are disclosed for treating diseases.. . ... Ligand Pharmaceuticals Incorporated

04/09/15 / #20150099720

Androgen receptor modulator compounds and methods

Provided herein are compounds having a structure selected from among formula (i), formula (ii), formula (iii), formula (iv), formula (v) and formula (vi) that are androgen receptor modulators and/or androgen receptor binding agents. Also disclosed are methods of making and using such compounds, including, but not limited to, using such compounds for treating various conditions.. ... Ligand Pharmaceuticals Incorporated

03/12/15 / #20150071857

Steroid hormone and cholesterol pathways as one unified homeostatic system

A unified homeostatic system of cholesterol and steroid hormone pathways is described, in which the uses or modulations of function of the homeostatic system of cholesterol and steroid hormone pathways are linked by lipoproteins, and are used or modulated to achieve a therapeutic benefit, to diagnose a disease or medical condition in humans, or to develop suitable active agents or combinations of active agents. Pharmaceutical compositions, methods of treatment, methods of drug development, and assay methods that rely on the new understanding of the homeostatic system are described.. ... Ligand Pharmaceuticals Incorporated

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009


This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. is not affiliated or associated with Ligand Pharmaceuticals Incorporated in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Ligand Pharmaceuticals Incorporated with additional patents listed. Browse our Agent directory for other possible listings. Page by